phenylephrine has been researched along with Disease Exacerbation in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, MJ; Lee, H; Lee, YB; Park, HM; Park, KH; Shin, DH; Shin, DJ; Sung, YH; Yang, JW | 1 |
| Che, Y; Deng, W; Jin, YG; Liao, HH; Tang, QZ; Wang, SS; Wei, WY; Yang, Z; Zhang, N | 1 |
| Chen, J; Chen, L; Chen, W; Chen, Y; Liu, X; Sun, G; Wu, X; Zhang, Y; Zhao, Y | 1 |
| Asakura, M; Bin, J; Cao, S; Huang, X; Kitakaze, M; Liao, Y; Wei, X; Wu, B; Xu, D; Xuan, W; Zeng, Z; Zhao, J | 1 |
| Da Silva, RC; da Silva-Santos, JE; de Souza, P | 1 |
| Hikoso, S; Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Otsu, K; Sakata, Y; Takeda, Y; Yamamoto, K | 1 |
| Cokkinos, DV; Galanopoulos, G; Gavra, M; Mourouzis, I; Pantos, C; Perimenis, P; Spanou, D | 1 |
| Choi, JY; Hong, JM; Huh, K; Lee, JS; Lim, TS; Shin, DH | 1 |
| Antonopoulos, A; Georgiou, EK; Kyriakidis, M; Nikolopoulos, D; Proukakis, C | 1 |
| Fox, JL; Kaplan, JR; Manuck, SB; Suparto, IH; Williams, JK | 1 |
| Bingley, JA; Brown, L; Campbell, JH; Rolfe, BE; Stamatiou, S; Thomas, AC; World, CJ; Worth, NF | 1 |
| Brancaleone, V; Bucci, M; Cicala, C; Cirino, G; Di Lorenzo, A; Farneti, S; Fiorucci, S; Lin, MI; Pinto, A; Roviezzo, F; Sessa, WC | 1 |
| Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H | 1 |
| Arimoto, T; Bilim, O; Goto, K; Ishino, M; Kitahara, T; Kubota, I; Nakajima, O; Niizeki, T; Sasaki, T; Suzuki, S; Takeishi, Y; Walsh, RA | 1 |
14 other study(ies) available for phenylephrine and Disease Exacerbation
| Article | Year |
|---|---|
The role of phenylephrine in patients with small deep subcortical infarct and progressive weakness.
Topics: Aged; Anticoagulants; C-Reactive Protein; Cerebral Infarction; Disease Progression; Female; Hemoglobins; Homocysteine; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Phenylephrine; Pulse Wave Analysis; Regression Analysis; Retrospective Studies; Stroke; Tomography Scanners, X-Ray Computed; Vasoconstrictor Agents | 2017 |
Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
Topics: Animals; Antioxidants; Aorta; Body Weight; Cardiomegaly; Cardiotonic Agents; Disease Progression; Drug Administration Schedule; Endoplasmic Reticulum Stress; Flavones; Gene Expression; Heart; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Organ Size; Oxidative Stress; Phenylephrine; Primary Cell Culture | 2017 |
The long noncoding RNA XIST protects cardiomyocyte hypertrophy by targeting miR-330-3p.
Topics: Animals; Cardiomegaly; Disease Progression; Mice; MicroRNAs; Myocytes, Cardiac; Phenylephrine; Protective Agents; RNA, Long Noncoding; S100 Calcium Binding Protein beta Subunit | 2018 |
Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
Topics: Animals; Aortic Valve Stenosis; Calcineurin; Calgranulin A; Calgranulin B; Cardiomyopathy, Hypertrophic; Cells, Cultured; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Genetic Vectors; Heart Failure; Hypertrophy; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Rats; Recombinant Fusion Proteins; RNA, Messenger | 2015 |
Increased diuresis, renal vascular reactivity, and blood pressure levels in young rats fed high sodium, moderately high fructose, or their association: a comparative evaluation.
Topics: Animals; Creatinine; Diet, Carbohydrate Loading; Disease Progression; Diuresis; Fructose; Hypertension; Kidney; Male; Phenylephrine; Rats, Wistar; Sodium Chloride, Dietary; Sodium, Dietary; Tachycardia; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Weaning; Weight Gain | 2016 |
Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Corticosterone; Disease Progression; Gene Expression; Glucocorticoids; Heart Failure; Male; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Phenylephrine; Rats; Rats, Inbred Dahl; Steroids | 2009 |
Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism.
Topics: Animals; Animals, Newborn; Disease Progression; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Heart Failure; Hypothyroidism; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myosins; Phenylephrine; Protein Isoforms; Rats; Rats, Wistar; Signal Transduction; Thyroid Hormone Receptors alpha; Thyroid Hormones; TOR Serine-Threonine Kinases; Ultrasonography | 2010 |
Induced-hypertension in progressing lacunar infarction.
Topics: Aged; Cardiotonic Agents; Cerebral Revascularization; Disease Progression; Female; Humans; Hypertension; Male; Middle Aged; Phenylephrine; Prospective Studies; Registries; Retrospective Studies; Stroke, Lacunar | 2011 |
Blood pressure elevation after phenylephrine infusion may adversely affect myocardial perfusion in patients with coronary artery disease.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Disease Progression; Electrocardiography; Female; Greece; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Reperfusion; Phenylephrine; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Statistics as Topic; Thallium Radioisotopes; Ventricular Function, Left | 2002 |
Effects of exercise on cardiovascular outcomes in monkeys with risk factors for coronary heart disease.
Topics: Adrenocorticotropic Hormone; Animals; Blood Pressure; Coronary Artery Disease; Coronary Vessels; Diet, Atherogenic; Disease Progression; Heart Rate; Hydrocortisone; Lipids; Macaca fascicularis; Male; Phenylephrine; Physical Conditioning, Animal; Risk Factors; Social Behavior; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2003 |
Leukaemia inhibitory factor retards the progression of atherosclerosis.
Topics: Acetylcholine; Animals; Arteriosclerosis; Blotting, Western; Carotid Arteries; Disease Progression; Enzyme Inhibitors; Humans; Immunohistochemistry; In Vitro Techniques; Interleukin-6; Leukemia Inhibitory Factor; Male; Models, Animal; Molecular Chaperones; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; Phenylephrine; Proteins; Rabbits; Serotonin; Vasoconstrictor Agents | 2003 |
Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression.
Topics: Adrenergic beta-Agonists; Animals; Aorta; Cattle; Caveolin 1; Caveolins; Cell Line; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Progression; Dopamine; Down-Regulation; Glycosuria; Humans; Hyperglycemia; Isoproterenol; Mice; Mice, Inbred NOD; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Receptor, Insulin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Serotonin; Vasodilation | 2004 |
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprolol; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Enzyme Induction; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertrophy; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Pressure; Rats; RNA, Messenger; Transcription, Genetic; Vasodilator Agents | 2004 |
Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
Topics: Animals; Aorta, Thoracic; Blotting, Western; Cardiomegaly; Diacylglycerol Kinase; Diglycerides; Disease Models, Animal; Disease Progression; Fetal Proteins; Fibrosis; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Isoenzymes; Ligation; Mice; Mice, Transgenic; Myocardium; Organ Size; Phenylephrine; Protein Kinase C; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel; Ventricular Function, Left | 2008 |